Results of sclerotherapy for bleeding esophageal varices in patients with schistosomal liver disease. A retrospective study

Hepato-Gastroenterology

Volumn 47, Issue 32, 2000, Pages 424-428

  Ravera, Maurizio ^a,b   Cocozza, Eugenio ^a   Pidoto, Rocco Roberto ^a  

^a Regional Teaching Hospital   (Uganda)

^b C/o AVSI ^*  (Uganda)

Author keywords

Bleeding esophageal varices; Schistosomal liver disease; Sclerotherapy

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DEVICE; DIGESTIVE TRACT ENDOSCOPY; ECHOGRAPHY; EMERGENCY; ENDOSCOPY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HEMATEMESIS; HUMAN; LIVER FIBROSIS; MALE; MORTALITY; PARASITIC LIVER DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCLEROTHERAPY; SURVIVAL;

ADOLESCENT; ADULT; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER DISEASES, PARASITIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCHISTOSOMIASIS MANSONI; SCLEROTHERAPY;

EID: 0034004053     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. 1 Symmer W St C: Note on a new form of liver cirrhosis due to the presence of the ova of Bilharzia haematobia. Journal of Pathology and Bacteriology 1904; 9:237-239.
2. 2 Mousa AH: Hepatosplenic schistosomiasis (endemic hepatosplenomegaly). Egypt J Bilhar 1975; 2:1-21.
3. 3 Abdel-Wahab MF, Mahmoud SS: Schistomiasis mansoni in Egypt. Clin Trop Med Comm Dis 1987; 2:371-395.
4. 4 Warren KS: Schistosomiasis. In: Weathrall DJ, Ledingham JGG, Warrel DA (Eds.). Oxford Textbook of Medicine, Oxford: University Press, 1987; pp. 5571-5577.
5. 5 De Franchis R, Bianchi M, Primigiani M: Terapia non chirurgica dell'ipertensione portale. In: Bianchi Porro G, Pace F (Ed.). Argomenti di Patologia Esofagea, Springer-Verlag, Milano, 1995; pp. 165-195.
6. 6 NIEC (The North Italian Endoscopic Club for the study and the treatment of esophageal varices): Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988; 319:983-989.
7. 7 Pagliaro L, D'Amico G, Pasta L, Politi F, Vizzini G, Traina M, Madonia S, Luca D, Guerrera D, Puleo A, D'Antoni A: Portal Hypertension in cirrhosis: Natural History. In: Bosch J, Groszmann RJ (Ed.). Portal Hypertension: Pathophysiology and Treatment. Oxford: Blackwell Scientific Publications, 1994; pp. 72-92.
8. 8 Barsoum MS, Bolous FI, El-Rooby AA, Rizk-Allah MA, Ibrahim AS: Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices. Br J Surg 1982; 69:76-78.
9. 9 EVASP (The Copenhagen Esophageal Varices Sclerotherapy Project): Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized munticenter trial. N Engl J Med 311:1594-1660.
10. 10 Paquet KJ, Feussner H: Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology (1985) 5:580-583.
11. 11 Soederlund C, Ihre T: Endoscopic sclerotherapy vs. conservative management of bleeding oesophageal varices. A 5-year prospective controlled trial of emergncy and long-term treatment. Acta Chir Scand (1985) 151: 449-456.
12. 12 Larson AW, Cohen H, Zweiban B, Chapman D, Gourdji M, Korula J, Weiner J: Acute esophageal varices sclerotherapy. Results of a prospective randomized controlled trial. JAMA 1986; 255:497-500.
13. 13 Moreto M, Zaballa M, Bernal A, Ibanez S, Ojembarrena E, Rodriguez A: A randomized trial of tamponade or sclerotherapy as immediate treatment for bleeding oesophageal varices. Surg Gynecol Obstet 1988; 167:331-334.
14. 14 Westaby D, Hayes PC, Gimson AES, Polson RJ, Williams R: Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology 1989; 9:274-277.
15. 15 Alexandrino P, Alves MM, Fidalgo P, Matos L, Esteves AV, Veloso J, Oliveira AG, Moura MC: Is sclerotherapy the first choice treatment for active oesophageal variceal bleeding in cirrhotic patients? J Hepatol 1990; 11(suppl 2):S1. (Abstract)
16. 16 Di Febo G, Siringo M, Vacirca M, Santoro P, Merighi S, Mustafal S, Barbara L: Somatostatin (SMS) and urgent sclerotherapy (US) in active oesophageal variceal bleeding. Gastroenterology 1990; 98:S583. (Abstract)
17. 17 Planas R, Quer JC, Boix J, Canet J, Armengol M, Cabre E, Pintanel T, Humbert P, Oller B, Gasull MA: A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding. Gastroenterology 1992; 102:A869. (Abstract)
18. 18 Shields R, Jenkins SA, Baxter JN, Kingsnorth A, Ellenbogen S, Makin CA, Gilmore I, Morris AI, Ashby D, West CR: Prospective randomized controlled trial comparing somatostatin and injection sclerotherapy in the control of acute variceal hemorrhage. J Hepatol 1992; 16:128-137.
19. 19 Jenkins SA, Copeland G, Kingsnorth A, Shields R: A prospective randomized controlled clinical trial comparing Sandostatin (SMS) and injection sclerotherapy in the control of acute variceal hemorrhage: an interim report. Gut 1992; S56. (Abstract)
20. 20 Sung JJY, Chung SCS, Lai CW, Chan FKL, Leung JWC, Yung MY, Kassianides C, Li AKC: Octreotide infusion or emergency sclerotherapy for variceal hemorrhage. Lancet 1993; 342:637-641.
21. 21 Westaby D, Macdougall BRD, Williams R: Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial. Hepatology 1985; 5:827-830.
22. 22 Terblanche J, Borrman PC, Kahn D, Jonker MAT, Campbell JAH, Wright J, Kirsch R: Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. Lancet 1983; 2:1328-1332.
23. 23 Korula J, Balart L, Radvan G, Zweiban BE, Larson AW, Kao HW, Yamada S: A prospective randomized controlled trial of chronic esophageal variceal sclerotherapy. Hepatology 1985; 5:584-589.
24. 24 Burroughs AK, McCormick PA, Siringo S, Phillips A, Sprengers D, McIntyre N: Prospective randomized trial of long term sclerotherapy for variceal rebleeding using the same protocol to treat rebleeding in all patients. Final report. J Hepatology 1989; 9(Suppl 1):S12. (Abstract)
25. 25 Gregory PB: Sclerotherapy for male alcoholics with cirrhosis who have bled from esophageal varices: results of a randomized, multicenter trial. Gastroenterology World Congresses Proceedings FP1193, 1990. (Abstract)
26. 26 Rossi V, Calés P, Pascal JP, Charneau J, Person B, Pujol P, Valentin S, D'Aubigny N, Joubaud F, Boyer J: 1991 Prevention of recurrent bleeding in alcoholic cirrhotic patients: a prospective controlled trial of propanolol and sclerotherapy. J Hepatol 1990; 12:283-289.
27. 27 Sauerbruch T, Weinzierl M, Kopeke W, et al: Long-term sclerotherapy of bleeding esophageal varices in patients with liver cirrhosis. An evaluation of mortality and rebleeding risk factors. Scand J Gastroenterol 1985; 20:51-58.
28. 28 Sauerbruch T, Weinzierl M, Ansari H, et al: Injection sclerotherapy of esophageal variceal hemorrhage. A prospective long-term follow-up study. Endoscopy 1987; 19:181-184.
29. 29 Olsson R: The natural history of oesophageal varices. A retrospective study of 224 patients with liver cirrhosis. Digestion 1972; 6:65-74.
30. 30 El-Zayadi A, El-Din SS, Kabil SM: Endoscopic sclerotherapy versus medical treatment for bleeding esophageal varices in patients with schistosomal liver disease. Gastrointest Endosc 1988; 34:314-317.
31. 31 Mohamed AE, Al-Karawi MA, Al-Otaibi R, Hanid MA: Result of sclerotherapy in 100 patients: comparison of the outcome between schistosomiasis and hepatitis B. Hepatogastroenterology 1989; 36:333-336.
32. 32 El-Shiekh-Mohamed AR, Al-Karawi MA, Yasawy MI: Organ involvement in hepato-intestinal schistosomiasis. Hepatogastroenterology 1994; 41:370-376.
33. 33 Al Karawi MA, Mohamed AE, Hanid MA, et al: Favourable outcome in sclerotherapy for bleeding oesophageal varices in schistosomiasis: Results in 30 patients. J Gastroenterol Hepatology 1986; 1:151-57.
34. 34 Yassin YM, Sherif SM: Randomized controlled trial of injection sclerotherapy for bleeding oesophageal varices - an interim report. Br J Surg 1983; 70:20-22.
35. 35 Bessa SM, Helmy I: Injection sclerotherapy for oesophageal varices caused by schistosomal hepatic fibrosis. Surgery 1985; 97:164-168.
36. 36 Homeida M, Ahmed S, DaFalle A, Suliman S, Eltom I, Nash T, Bennett JL: Morbidity associated with Schistosoma mansoni infection as determined by ultrasound: a study in Gezira, Sudan. Am J Trop Med Hyg 1988; 39:196-201.
37. 37 Giocanni GC, Vanancio AF, Alvaro M: Hepatosplenic schistosomiasis mansoni: Ultrasound manifestations. Radiology (1984) 153:777-780.
38. 38 Doehring Schwerdtferger E, Mohammed Ali G, Abdel-Rahim IM, Kardorff R, Franke D, Kaiser C, Elsheikh M, Enrich JHH: Sonomorphological abnormalities in Sudanese children with Schistosoma mansoni infection: a proposed staging system for field diagnosis of periportal fibrosis. Am J Trop Med Hyg 1989; 41:63-69.
39. 39 Doehring Schwerdtferger E, Abdel-Rahim IM, Mohamed Ali Q, Elsheikh M, Schlake J, Kardorff R, Franke D, Kaiser C, Enrich JHH: Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: evaluation of morbidity. Am J Trop Med Hyg 1990; 42:581-586.
40. 40 Abdel-Latif Z, Abdel-Wahab MF, El-Kady NM: Evaluation of portal hypertension in cases of hepatosplenic schistosomiasis using ultrasound. J Clin Ultrasound 1981; 9:409-412.
41. 41 Abdel-Wahab MF, Esmat G, Milad M, Abdel-Razek S, Strickland T: Characteristic sonographic pattern of Schistosomal hepatic fibrosis. Am J Trop Med Hyg 1989; 40:72-76.
42. 42 Ravera M, Reggiori A, Cocozza E, Andreata M, Ciantia F, Riccioni G: Hepatosplenic Schistosomiasis in Uganda: Ultrasonographic study. La Medicina tropicale 1994; 10:3-4.
43. 43 WHO: Meeting on Ultrasonography in Schistosomiasis: Proposal for a practical guide to the standardized use of ultrasound in the assessment of pathological changes. In: WHO Special Program for Research and Training in Tropical Diseases, 1990; 91:3.
44. 44 Zdenek M: Terminologia, definizioni e criteri diagnostici in endoscopia digestiva, 2a Ed. Verlag Bad Homburg: Normed 1990; p. 46.
45. 45 Garcia Samaniego J, Castanos Mollor R, Moreno Otero R, et al: Effectiveness of endoscopic sclerotherapy in the treatment of bleeding oesophageal varices. Rev Clin Esp 1993; 192:7-10.
46. 46 Ohta M, Hashizume M, Kamakura T, et al: Endoscopic injection sclerotherapy for esophageal varices in the elderly. World J Surg 1994; 18:764-768.
47. 47 Sarin SK, Mishra SP, Sachdev G, et al: Ethanolamine oleate versus alcohol as a variceal sclerosant: a prospective, randomized, controlled trial. Am J Gastroenterol 1988; 83:526-530.
48. 48 Sarin SK, Nanda R, Sachdev G: Relative efficacy and safety of absolute alcohol and 50% alcohol as a variceal sclerosant. Gastrointest Endosc 1987; 33:362-365.
49. 49 Nishida R, Inoue R, Takimoto Y, et al: Endoscopic sclerotherapy in a rat model of esophageal varices. Scand J Gastroenterol 1995; 30(5):489-496.
50. 50 Atamkurj SP, Bhargava DK, Sharma MP: Endoscopic sclerotherapy for oesophageal varices: a prospective, randomized trial of absolute alcohol versus polidocanol. Indian J Gastroenterol 1988; 7:87-89.
51. 51 Paoluzi P, Pietroiusti A, Ferrari S, et al: Absolute alcohol in esophageal vein sclerosis. Gastrointest Endosc 1988; 34:400-402.
52. 52 Duhamel O, Carle JP, Daures JP, et al: Primary prevention of digestive hemorrhage, caused by rupture of esophageal varices, by endoscopic sclerotherapy in patients with liver cirrhosis. Multicenter randomized controlled study. Gastroenterol Clin Biol 1994; 18(1):57-62.
53. 53 Kahn D, Jones B, Bornman PC, et al: Incidence and management of complication after injection sclerotherapy: a ten year prospective evaluation. Surgery 1989; 105:160-165.
54. 54 Sivak MV: Esophageal varices. In: Sivak MV (Ed.). Gastroenterologic endoscopy. Philadelphia: Saunders, 1987: pp. 342-372.
55. 55 Korula J, Baydur A, Sasson C, et al: Effect of esophageal variceal sclerotherapy (EVS) on lung function. A prospective controlled study. Arch Int Med 1986; 146:1517-1520.
56. 56 Hatz C, Jenkins JM, Ali QM, Abdel-Wahab MF, Cerri GG, Tanner M: A review of the literature on the use of ultrasonography in schistosomiasis with special reference to its use in field studies. Acta Trop 1992; 51:15-28.
57. 57 Cordeiro F: Sclerotherapy of esophageal varices in Schistosomiasis patients. Mem Ins Oswaldo Cruz 1992; 87:353-355.
58. 58 Hasan F, Levine BA: The role of endoscopic sclerotherapy in the management of esophageal varices. In: Scarpignato C, Modlin IM (Eds.). Management of esophageal varices, pharmacological, endoscopic and surgical approach. Digestive Diseases 1992; 10(Suppl 1):38-45.
59. 59 The PROVA Study Group: Prophylaxis of the first hemorrhage from esophageal varices by sclerotherapy, propanolol or both in cirrhotic patients: a randomized multicenter trial. Hepatology 1991; 14(6):1016-24.
60. 60 Beppu K, Inokuchi K, Koyanagy N, et al: Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointestinal Endoscopy 1981; 27(n.4):213.
61. 61 Ravera M, Reggiori A, Cocozza E, Andreata M, Ciantia F, Riccioni G: Clinical aspects and imaging patterns with ultrasonography and endoscopy in hepatosplenic schistosomiasis in Uganda. East Afr Med J 1996; 73(4):228-232.